Nantahala Capital Management »

Cortexyme shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.0M 3.1M 1.63
2025-06-30 $4.2M 2.5M 1.65

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Edwards Lifesciences Put Option (EW)
Hilton Grand Vacations (HGV)
Establishment Labs Holdings Ord (ESTA)
Peloton Interactive Cl A Com (PTON)
Spdr Series Trust S&p Biotech Put Option (XBI)
Herbalife Com Shs (HLF)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Viatris Call Option (VTRS)
Abivax Sa Sponsored Ads (ABVX)
Xtant Med Hldgs Com New (XTNT)
Fulcrum Therapeutics (FULC)

View all positions for Nantahala Capital Management

Top funds holding Cortexyme

Nantahala Capital Management
Vanguard Group
Millennium Management
Ieq Capital
ADAR1 Capital Management
Almitas Capital
Renaissance Technologies
Geode Capital Management
BlackRock
HighTower Advisors
Union Square Park Capital Management
Marshall Wace
State Street Corporation
Alphabet
Shay Capital

View all funds holding Cortexyme